 | • レポートコード：MRC2203A743 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料では、世界の解剖病理学市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品・サービス別（機器、消耗品、サービス）分析、用途別（病気診断、薬物送達・開発、その他）分析、エンドユーザー別（病院、研究所、診断研究室、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来の傾向などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の解剖病理学市場規模：製品・サービス別（機器、消耗品、サービス） ・世界の解剖病理学市場規模：用途別（病気診断、薬物送達・開発、その他） ・世界の解剖病理学市場規模：エンドユーザー別（病院、研究所、診断研究室、その他） ・世界の解剖病理学市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Thermo Fisher Scientific Inc.、Quest Diagnostics Incorporated、Laboratory Corporation of America Holdings、...） ・市場機会・将来の傾向 |
The anatomic pathology market will show rapid growth due to the high incidence of cancer and other target diseases, growing focus on personalized medicine and a substantial number of supporting programs and training modules by government.
There is rapid growth in the geriatric population and the increasing incidence rate of cancer and other chronic diseases. Rising cases of chronic disease and increasing requirements to address the timely diagnosis of medical conditions are driving the market.
Due to the rapid increase in the prevalence of cancer, there is increasing usage of advanced pathology equipment such as staining systems, gross imaging, and digital microscopes that are poised to improve anatomic pathological practices to some extent. Digital imaging solutions also offer specificity and accuracy-related benefits over conventional techniques, which in turn, boosts the service uptake rate in the overall market.
In addition, growing awareness and an increase in the patient pool in developing countries is also driving the growth of the market. Moreover, the increase in healthcare expenditure and increase in usage of biomarkers during disease diagnosis are also found driving the Anatomic Pathology market.
Key Market Trends
Hospitals Segment is Expected to Dominate the Anatomic Pathology Market During the Forecast Period
Hospitals are expected to dominate the market owing to the high hospitalization rate of cancer patients, coupled with a substantial number of frequent readmissions in hospitals. Moreover, the presence of well-developed infrastructure, as well as well-trained staff in hospital-based pathological laboratories, stimulates the progression of the hospital segment. The segment is also expected to benefit from an increasing number of initiatives undertaken by public and private agencies to promote advanced healthcare systems.
On the other side, a large number of clinical trials through various ongoing projects has spurred the progression of the research laboratories segment. Research laboratories are engaged in offering rapid and comprehensive information about the functioning of diseased tissues, with an overall objective of achieving a high degree of patient satisfaction that is expected to grow in the upcoming future.
North America is Found Leading the Anatomic Pathology Market
North America has been accounted for the largest revenue share due to the presence of major players and supportive government initiatives pertaining to training pathological programs. There is also an easy accessibility to advanced technologies, government initiatives for screening cancer patients, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region that are the major factors driving the growth of the Anatomic Pathology market in North America.
Competitive Landscape
Product innovation and ongoing R&D activities to develop advanced technologies has helped in boosting the growth of the market. Various strategies and collaborations are being adopted by these key players to maintain their market share. The key players are found implementing multiple strategies to maintain their significant share in the marketplace during the forecast period. The strategies implemented include collaborative development, business expansion, and product developments.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Incidence of Cancer and Other Target Diseases
4.2.2 Growing Focus on Personalized Medicine
4.2.3 High Usage of Advanced Pathology Equipment
4.3 Market Restraints
4.3.1 Stringent Government Regulations Pertaining to Anatomic Pathology
4.3.2 Lack of Skilled Professionals
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product & Services
5.1.1 Instruments
5.1.2 Consumables
5.1.3 Services
5.2 By Application
5.2.1 Disease Diagnosis
5.2.2 Drug Discovery and Development
5.2.3 Others
5.3 By End User
5.3.1 Hospitals
5.3.2 Research Laboratories
5.3.3 Diagnostic Laboratories
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Thermo Fisher Scientific Inc.
6.1.2 Quest Diagnostics Incorporated
6.1.3 Laboratory Corporation of America Holdings
6.1.4 F. Hoffmann-La Roche Ltd.
6.1.5 Agilent Technologies, Inc.
6.1.6 Cardinal Health
6.1.7 Sakura Finetek USA, Inc.
6.1.8 NeoGenomics Laboratories, Inc.
6.1.9 BioGenex
6.1.10 Bio SB
7 MARKET OPPORTUNITIES AND FUTURE TRENDS